Activation of cAMP-responsive-element-binding protein by PI3 kinase and p38 MAPK is essential for elevated expression of transforming growth factor β2 in cancer cells

Journal of Interferon and Cytokine Research

Volumn 30, Issue 9, 2010, Pages 677-681

  Wan, Youzhong ^a,b   Yang, Maojing ^a   Kolattukudy, Sunny ^a   Stark, George R ^a,b   Lu, Tao ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; COMPLEMENTARY DNA; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; TRANSFORMING GROWTH FACTOR BETA2;

ARTICLE; BREAST CANCER; CANCER CELL; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GLIOMA CELL; HUMAN; HUMAN CELL; KIDNEY CANCER; LUNG CANCER; PLASMID; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; WESTERN BLOTTING;

CELL LINE, TUMOR; CHROMONES; CREB-BINDING PROTEIN; CYCLIC AMP; FEMALE; HUMANS; IMIDAZOLES; MALE; MORPHOLINES; NEOPLASMS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PROMOTER REGIONS, GENETIC; PROTEIN KINASE INHIBITORS; PYRIDINES; RESPONSE ELEMENTS; TRANSFORMING GROWTH FACTOR BETA2; UP-REGULATION;

EID: 77956590943     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.2009.0117     Document Type: Article

References (14)

1. Cuenda A, Rousseau S. 2007. p38 MAP-kinases pathway regulation, function and role in human diseases [Review]. Biochim Biophys Acta 1773:1358-1375.
2. Du K, Montminy M. 1998. CREB is a regulatory target for the protein kinase Akt/PKB. J Biol Chem 273:32377-32379.
3. Garcia-Echeverria C, Sellers WR. 2008. Drug discovery approaches targeting the PI3K/Akt pathway in cancer [Review]. Oncogene 27:5511-5526.
4. Lu T, Burdelya LG, Swiatkowski SM, Boiko AD, Howe PH, Stark GR. 2004a. Secreted transforming growth factor-b2 activates NF-kB, blocks apoptosis, and is essential for the survival of some tumor cells. Proc Natl Acad Sci\USA 101: 7112-7117.
5. Lu T, Sathe SS, Swiatkowski SM, Hampole CV, Stark GR. 2004b. Secretion of cytokine and growth factors as a general cause of constitutive NF-kB activation in cancer. Oncogene 23:2138-2145.
6. Lu T, Tian L, Han Y, Vogelbaum M, Stark GR. 2007. Dose-dependent cross-talk between the transforming growth factor-b and interleukin-1 signaling pathways. Proc Natl Acad Sci\USA 104:4365-4370.
7. Mayr B, Montminy M. 2001. Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat Rev Mol Cell Biol 2:599-609.
8. Oft M, Heider KH, Beug H. 1998. TGF-b signaling is necessary for carcinoma cell invasiveness and metastasis. Curr Biol 8: 1243-1252.
9. O'Reilly MA, Geiser AG, Kim SJ, Bruggeman LA, Luu AX, Roberts AB, Sporn MB. 1992. Identification of an activating transcription factor (ATF) binding site in the human transforming growth factor-b2 promoter. J Biol Chem 267:19938-19943.
10. Pugazhenthi S, Boras T, O'Cnnor D, Meintzer MK, Heidenriech KA, Reusch JE. 1999. Insulin-like growth factor 1-mediated activation of the transcription factor cAMP response element-binding protein in PC12 cells. J Biol Chem 274:2829-2837.
11. Sathe SS, Sizemore N, Li X, Vithalani K, Commane M, Swiatkowski SM, Stark GR. 2004. Mutant human cells with constitutive activation of NF-kB. Proc Natl Acad Sci\USA 101:192-197.
12. Wakefield LM, Roberts AB. 2002. TGF-b signaling: positive and negative effects on tumorigenesis. Curr Opin Genet Dev 12: 22-29.
13. Wan Y, Xiao H, Affolter J, Kim TW, Bulek K, Chaudhuri S, Carlson D, Hamilton T, Mazumder B, Stark GR, Thomas J, Li X. 2009. Interleukin-1 receptor-associated kinase 2 is critical for lipopolysaccharide-mediated post-transcriptional control. J Biol Chem 284:10367-10375.
14. Xu X, Brodie SG, Yang X, Im Y, Parks WT, Chen L, Zhou YX, Weinstein M, Kim ST, Deng C. 2000. Haploid loss of the tumor suppressor Smad4/Dpc4 initiates gastric polyposis and cancer in mice. Oncogene 19:1868-1874.